Back to results
US 2019/0054102 A1Published application
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
AssigneeGenentech, Inc.
InventorsJohn A. Flygare, Thomas H. Pillow
Life of this patent
Estimating the term…
Abstract
The invention provides antibody-drug conjugates comprising an antibody conjugated to an anthracycline drug moiety via a disulfide linker, anthracycline disulfide intermediates, and methods of using the antibody-drug conjugates.
Claims18
A linker-drug intermediate of Formula I
- Ant-L-(Z)m—X I
- wherein Ant is selected from the structure:
- where the wavy line indicates the attachment to L;
- L is a linker selected from —CH2O—, —CH2N(R)—, —N(R)—, —N(R)(C1-C12 alkylene)-, —N(R)(C2-C8 alkenylene)-, —N(R)(C2-C8 alkynylene)-, —N(R)(CH2CH2O)n—, and the structure:
- where the wavy lines indicate the attachments to Ant and Z;
- and
- Z is an optional spacer selected from —CH2C(O)—, —CH2C(O)NR(C1-C12 alkylene)-, and the structure:
- where the wavy lines indicate the attachments to L and X;
- R is H, C1-C12 alkyl, or C6-C20 aryl;
- Z1 is selected from —(C1-C12 alkylene)-, —(C2-C8 alkenylene)-, —(C2-C8 alkynylene)-, —O(C1-C12 alkylene)-, —O(C2-C8 alkenylene)-, —O(C2-C8 alkynylene)-, and (CH2CH2O)n—;
- m is 0 or 1;
- n is 1 to 6;
- X is pyridyl disulfide where pyridyl is optionally substituted with one or more groups selected from NO2, Cl, F, CN and Br;
- and
- alkylene, alkenylene, alkynylene, alkyl, and aryl are optionally substituted with one or more groups selected from F, Cl, Br, N(CH3)2, and OCH3.
12 more elements
Dependencies are inferred from the claim text.